Welcome to LookChem.com Sign In|Join Free
  • or
N-tert-butyl-4'-forMylbiphenyl-2-sulfonaMide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

851902-28-8

Post Buying Request

851902-28-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

851902-28-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 851902-28-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,9,0 and 2 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 851902-28:
(8*8)+(7*5)+(6*1)+(5*9)+(4*0)+(3*2)+(2*2)+(1*8)=168
168 % 10 = 8
So 851902-28-8 is a valid CAS Registry Number.

851902-28-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-tert-butyl-2-(4-formylphenyl)benzenesulfonamide

1.2 Other means of identification

Product number -
Other names 4'-formylbiphenyl-2-sulfonic acid t-butylamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:851902-28-8 SDS

851902-28-8Relevant academic research and scientific papers

Dual-acting antihypertensive agents

-

Page/Page column 43, (2008/12/07)

The invention is directed to compounds of formula I: wherein Ar, r, R3, X, and R5-7 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds of formula I have AT1 receptor antagonist activity and neprilysin inhibition activity. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and a process and intermediates for preparing such compounds.

Novel cyclopentane dicarboxamide sodium channel blockers as a potential treatment for chronic pain

Shao, Pengchang P.,Ok, Dong,Fisher, Michael H.,Garcia, Maria L.,Kaczorowski, Gregory J.,Li, Chunshi,Lyons, Kathryn A.,Martin, William J.,Meinke, Peter T.,Priest, Birgit T.,Smith, McHardy M.,Wyvratt, Matthew J.,Ye, Feng,Parsons, William H.

, p. 1901 - 1907 (2007/10/03)

A series of new voltage-gated sodium channel blockers were prepared based on the screening lead succinic diamide BPBTS. Replacement of the succinimide linker with the more rigid cyclic 1,2-trans-diamide linker was well tolerated. N-Methylation on the biph

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 851902-28-8